Ficalora Joins Patient Innovations Advisory Board

NEW YORK, July 30, 2019 /PRNewswire/ — Joseph R. Ficalora, President, Chief Executive Officer and a Director of New York Community Bancorp – the 25th largest bank holding company in the nation – has joined the Patient Innovations Advisory Board.

Under Mr. Ficalora’s leadership, the bank grew from a local savings bank to a regional banking powerhouse with 251 locations in five states.

Ken Greenberg, Patient Innovations Co-founder and President noted, “We are thrilled to have Joe Ficalora join our team. His business and financial acumen and desire for growth are a perfect fit and alignment with the PI mission.”

John M. Tabone, Chairman & CEO said, “It’s an honor and privilege to welcome Joe Ficalora to our Advisory Board. He represents an amazing addition to our fine team of healthcare leaders. Joe’s banking, business and growth skills – along with his strong commitment to community service – will help us steer Patient Innovations forward.”

Mr. Ficalora commented, “NYCB is a community bank committed to being a good neighbor. We’re here to serve our communities. The Patient Innovations OnTimeCare technology platform reduces endless waiting in doctors’ offices and helps make hospitals more efficient. This means greater access and a better patient experience for the communities we serve. Ultimately, this can slow the rising cost of healthcare. These are important goals that fit well with our mission to serve.”

See Mr. Ficalora’s bio here.

About Patient Innovations
Patient Innovations is converging technology, clinical insights and real-time provider and asset data to address the inefficiencies in patient access, healthcare delivery and compliance. Our interoperable RTLS platform manages content at scale and provides persisted datasets that drive optimal clinical workflows and insights that shape care decisions.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/ficalora-joins-patient-innovations-advisory-board-300892702.html

SOURCE Patient Innovations

Staff

Recent Posts

Cantargia Reports Progress Towards Start of DOD-Sponsored Clinical Trial of Nadunolimab in Leukemia

LUND, SWEDEN / ACCESSWIRE / March 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq…

3 hours ago

RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting

Relief Therapeutics Calls Extraordinary General Meeting Anticipated Board of Directors OverhaulGENEVA, SWITZERLAND / ACCESSWIRE /…

3 hours ago

PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease

Pivotal Trial for Improving Overall Function and Quality of LifeSALT LAKE CITY--(BUSINESS WIRE)--#medicaldevices--PhotoPharmics, a pioneer…

12 hours ago

AARC Celebrates Introduction of the SOAR Act in the House of Representatives

Bill passage key to supplemental oxygen access and adequate reimbursementIRVING, TX / ACCESSWIRE / March…

15 hours ago

She Is Not Skipping a Beat, and Patients Are Noticing

NORTHAMPTON, MA / ACCESSWIRE / March 26, 2024 / Quest Diagnostics At Quest for 2…

15 hours ago